Relating To Health And Safety- Immunization Against Covid-19
Impact
The bill imposes specific requirements on the state's health framework by potentially increasing the overall vaccination rates within Rhode Island. It seeks to unify immunization scheduling, providing clear guidelines about exemptions for individuals unable to comply due to medical reasons. Additionally, the civil penalties outlined in the bill are significant, ensuring that any violations result in substantial fines to further enforce compliance. This legislation aims to strengthen public health safety through higher immunization levels, particularly vital during ongoing public health crises.
Summary
Bill S2552, known as the 'Immunization Against COVID-19' act, aims to mandate COVID-19 vaccinations for all residents of Rhode Island who are at least sixteen years old. The bill makes provisions for compliance where individuals are required to receive full immunization according to standards set by the state's department of health. It also mandates that parents or guardians are responsible for ensuring that minors under the age of sixteen are vaccinated. Significant penalties for non-compliance are outlined to encourage vaccination among the eligible population.
Contention
Despite the intentions behind S2552, the bill is not without controversy. Critics of the legislation have raised concerns about personal liberties and the ethical implications of mandating medical procedures. There are apprehensions regarding the enforcement mechanisms, particularly the imposition of financial penalties which may disproportionately affect low-income families. The requirement for minors to be vaccinated with parental consent has also faced scrutiny, as critics argue it infringes on parental rights and health autonomy.
Notable_points
S2552 foresees a well-defined route for health authorities to manage and enforce vaccination standards, allowing for the potential adoption of future immunizations as they become available. The bill's framework not only focuses on compliance but also emphasizes the importance of exemptions for medical reasons, which must be corroborated by licensed physicians. The implementation timeline is set for thirty days post-passage, indicating a swift transition to enforcing these new health protocols.
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.
Permits licensed pharmacists and nurse practitioners to prescribe and order COVID-19 immunizations; permits physicians to issue non-patient specific orders to pharmacists for COVID-19 immunizations for patients two years of age and older; permits pharmacists to issue patient specific orders for COVID-19 immunizations for patients two years of age and older.
Includes the COVID-19 immunization under the consent and reporting provisions required for pharmacy administered immunizations to individuals between nine (9) and eighteen (18) years of age.
Includes the COVID-19 immunization under the consent and reporting provisions required for pharmacy administered immunizations to individuals between nine (9) and eighteen (18) years of age.
Amends the definition of the practice of pharmacy to include the administration of all forms of influenza immunizations including COVID-19 to individuals over the age of 3 years pursuant to a valid prescription or prescriber approved protocol.
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; relates to insurance coverage for immunizations; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.